• SENSEX 78,079.96
    113.61 (+0.15%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • JSW Energy
    562.05 617.30(%)
  • Urban Company
    146.00 201.00(%)
  • HDFC Bank
    724.45 722.00(%)
  • ICICI Bank
    1,406.60 1,187.55(%)
  • Reliance Industries
    1,307.10 1,250.55(%)
  • Larsen & Toubro
    4,070.00 4,440.00(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Godrej Consumer
    938.90 1,308.40(%)
  • Netweb Technol.
    5,200.00 5,241.65(%)
  • Thyrocare Tech.
    594.30 342.55(%)
  • Fortis Health.
    904.95 1,105.00(%)
  • SBI
    1,073.20 798.60(%)
  • Astral
    1,599.00 1,767.95(%)
  • M & M
    3,440.00 3,840.00(%)
  • ITC
    279.50 426.50(%)
  • Cupid
    295.00 290.00(%)
  • Bajaj Finserv
    2,037.00 2,194.65(%)
  • Axis Bank
    1,215.30 1,041.30(%)
  • Solar Industries
    20,400.00 19,160.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Emcure Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16966.0
  • ISIN : INE168P01015
2,009.60 11 (0.55%)
  • As on 13 Aug 2026 (EOD)

  • Today’s Low

    1,983.30

  • Today’s High

    2,023.00

  • Open

    2,008.60

  • Perv Close

    1,998.70

  • 52W Low

    1,260.00

  • 52W High

    2,048.00

Key Indicators

  • P/E(TTM)

    45.97

  • Mar.Cap (₹Cr.)

    38,118.12

  • Div & Yield %

    0.18

  • Book Value(₹)

    195.63

  • Debt-Equity Ratio

    0.55

  • AGM Date

    12-Aug-2026

  • EPS

    43.64

  • P/E Ratio

    45.97

Financials Ratios

  • Debt-Equity Ratio

    0.86

  • Mar.Cap (₹Cr.)

    38,118.12

  • RONW (%)

    19.35

  • ROCE (%)

    18.23

Score Board

  • Equity (₹ in Cr.)

    189.68

  • BV (₹)

    195.60

  • Sales( ₹ in Cr.)

    5,243.19

  • NP (in Cr.)

    751.82

  • NP Var(%)

    161.0

  • Div%

    36.0

  • CPS (₹)

    52.60

  • EPS (₹)

    39.60

  • Traded Value (₹ in Lakhs)

    38,055.53

  • 52 Week High

    2,048.00

  • 52 Week Low

    1,260.00

  • Price BSE

    2006.0

  • Price NSE

    2,010.00

  • Market Capital( in Cr.)

    38,055.53

  • P/C Ratio

    38.10

  • P/E Ratio

    50.60

  • Price Vs.BV

    39.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 4,381.92 3,497.66 3,107.09 3,387.24 3,153.66 2,375.71
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,381.92 3,497.66 3,107.09 3,387.24 3,153.66 2,375.71
Other Income 142.48 138.26 125.35 132.68 111.91 137.62
Stock Adjustments 126.27 101.70 -14.45 36.10 107.96 -59.70
Total Income 4,650.67 3,737.62 3,217.99 3,556.02 3,373.53 2,453.63
EXPENDITURE :            
Raw Materials 2,133.68 1,464.67 1,199.25 1,354.99 1,354.36 751.46
Power and Fuel Cost 99.86 88.73 80.41 72.46 73.92 67.29
Employee Cost 782.31 706.41 649.18 603.95 550.96 545.35
Other Manufacturing Expenses 275.56 209.89 192.67 219.39 142.20 127.43
Selling and Administration Expenses 473.67 532.82 443.20 263.11 341.49 342.04
Miscellaneous Expenses 119.95 164.27 95.59 114.78 73.58 103.18
Employee Benefit Expenses 782.31 706.41 649.18 603.95 550.96 545.35
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,885.03 3,166.78 2,660.30 2,628.67 2,536.51 1,936.75
Operating Profit 765.64 570.83 557.69 927.36 837.02 516.88
Interest 112.96 166.09 166.83 145.14 123.34 137.22
Gross Profit 652.68 404.74 390.86 782.22 713.68 379.66
Depreciation 224.97 204.83 178.52 165.79 156.24 154.97
Profit Before Tax 427.71 199.91 212.34 616.43 557.44 224.69
Current Tax 112.71 38.58 53.10 168.72 141.13 72.81
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.13 0.50 -0.83 0.89 -4.15 -23.34
Reported Net Profit 317.13 160.83 160.06 446.81 420.48 175.21
Extraordinary Items 28.53 -1.64 -4.80 0.10 -13.20 -32.65
Adjusted Net Profit 288.60 162.47 164.86 446.71 433.68 207.86
Adjustment below Net Profit -1.21 -5.34 4.06 -0.79 0.11 -2.03
P & L Balance brought forward 1,695.08 1,593.84 1,465.89 1,877.11 1,474.61 1,349.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 54.26 36.17 857.24 18.09 48.27
P & L Balance carried down 2,011.00 1,695.08 1,593.84 1,465.89 1,877.11 1,474.61
Dividend 0.00 36.17 0.00 36.17 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 20.00 20.00 30.00 10.00 25.00
Dividend Per Share(Rs) 3.00 2.00 2.00 3.00 1.00 2.50
Earnings Per Share-Unit Curr 16.74 8.88 8.85 24.71 23.25 9.69
Earnings Per Share(Adj)-Unit Curr 16.74 - - - - -
Book Value 159.61 106.82 101.84 94.69 127.27 105.86
Book Value(Adj)-Unit Curr 159.61 - - - - -

Shareholding Pattern

  • Promoter Group

    77.83%

  • Public Share Holding

    22.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 433,932 433,932.00 433,932 433,932
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 433,932 0.23 433,932 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 118,166,268 62.30 118,166,268 16
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 29,028,000 15.30 29,028,000 2
Others 0 0.00 0 0
Sub Total 147,194,268 77.60 147,194,268 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,248,970 4.88 9,248,970 116
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,529,886 1.33 2,529,886 4
Mutual Funds / UTI 13,021,870 6.87 13,021,870 23
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 502,079 0.26 502,079 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 25,302,805 13.34 25,302,805 159
2] Non Institution
Bodies Corporate 2,222,865 1.17 2,222,865 382
Clearing Members 18,092 0.01 18,092 17
Directors of their Relatives 295,716 0.16 295,716 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,417,344 0.75 1,417,344 1,662
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 235,139 0.12 235,139 2,911
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,541,069 3.45 6,520,469 46
Individuals holding nominal share capital up to Rs. 1 lakh 5,699,009 3.00 5,699,005 119,731
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,103 0.00 2,103 4
Others 30,750 0.02 30,750 1
Sub Total 16,749,142 8.83 16,728,538 124,812
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 189,680,147 100.00 189,659,543 124,991

Company Background

Emcure Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Emcure Pharmaceuticals Ltd
  • BSE Code : 16966.0
  • ISIN : INE168P01015

  • Incorporation Year

    1981

  • Registered Office

    Plot # P-1 & P-2 IT BT Park
    Phase II MIDC Hinjawadi, Pune,
    Maharashtra-411057

  • Telephone

    +91 20 3507 0033/+91 20 3507 0000

  • FAX

  • Chairman

    SATISH RAMANLAL MEHTA

  • Managing Director

  • Company Secretary

    Amruta Jana Yangalwar

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Emcure Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Emcure Pharma 2,006.30 4,524.40 4,381.92 46.96 14.36
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77